ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 298

$480K Total Retail Price of All Prescriptions

Rank: 37 out of 298

349 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
FUROSEMIDE 524 513 1 5
AMLODIPINE BESYLATE 522 504 2 6
OMEPRAZOLE 519 505 3 3
SIMVASTATIN 474 444 4 2
LISINOPRIL 438 421 5 4
LEVOTHYROXINE SODIUM 436 436 6 1
WARFARIN SODIUM 334 314 7 7
METOPROLOL SUCCINATE 302 290 8 12
HYDROCHLOROTHIAZIDE 233 216 9 13
METFORMIN HCL 187 170 10 10
LOSARTAN POTASSIUM 186 163 11 18
HYDROCODONE-ACETAMINOPHEN 186 172 S3 11 8
ALLOPURINOL 173 166 13 28
POTASSIUM CHLORIDE 162 154 14 11
DONEPEZIL HCL 161 147 15 22
CITALOPRAM HBR 160 125 16 17
FINASTERIDE 158 158 17 66
GABAPENTIN 144 120 18 20
TAMSULOSIN HCL 138 133 19 24
ATENOLOL 127 126 20 16
ZOLPIDEM TARTRATE 127 127 20 25
CARVEDILOL 127 127 20 23
RISPERIDONE 123 117 23 54
ATENOLOL-CHLORTHALIDONE 111 111 24 165
DIGOXIN 109 97 25 27
METOPROLOL TARTRATE 106 90 26 9
ATORVASTATIN CALCIUM 102 102 27 14
DIOVAN 96 96 28 47
KLOR-CON M20 88 88 29 78
CRESTOR 86 84 30 26
GLIMEPIRIDE 83 79 31 60
TRAMADOL HCL-ACETAMINOPHEN 78 78 32 129
FENTANYL 77 71 S2 33 32
TERAZOSIN HCL 77 77 33 72
NAMENDA 75 75 35 35
NEXIUM 71 61 36 40
SERTRALINE HCL 71 69 36 19
ADVAIR DISKUS 70 66 38 46
KLOR-CON 10 70 70 38 61
BENAZEPRIL HCL 70 70 38 52
VENLAFAXINE HCL 67 67 41 187
MIRTAZAPINE 66 41 42 37
ISOSORBIDE MONONITRATE ER 63 63 43 45
DOXAZOSIN MESYLATE 63 49 43 77
GLYBURIDE 58 58 R 45 76
SPIRIVA 58 49 45 55
FLUOXETINE HCL 56 51 47 50
ENALAPRIL MALEATE 54 54 48 58
SPIRONOLACTONE 53 53 49 34
INSULIN SYRINGE 53 53 49 99
OXYBUTYNIN CHLORIDE 51 51 51 81
FLUTICASONE PROPIONATE 50 50 52 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.